St. Jude Introduces Allure Quadra To Hong Kong As It Seeks APAC Rebound For Pacemakers
This article was originally published in PharmAsia News
The first commercial implant for St. Jude’s Allure Quadra in Hong Kong is a sign for optimism for its pacemaker business after last year’s disappointments in Japan.
You may also be interested in...
St. Jude Medical’s pacemaker revenue dropped 12 percent year-over-year in the first quarter, but the firm says it has several products in the pipeline that could help it regain pacemaker market share in Europe and Japan.
Regulators in Southeast Asia are working to tighten bribery and corruption enforcement as part of a broader push ahead of an Association of Southeast Asian Nations trade pact in 2015 for greater transparency in pharmaceuticals.
Some health-focused Millennium Development Goals are likely to fail to reach a successful benchmark by 2015. Companies are exploring new partnership models for public health achievements.